Notes Payable - Additional Information (Details) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 20, 2024 |
Aug. 17, 2023 |
Jun. 29, 2023 |
May 18, 2023 |
Mar. 31, 2023 |
Feb. 21, 2023 |
Dec. 28, 2022 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Nov. 30, 2024 |
Dec. 01, 2023 |
Sep. 29, 2023 |
May 01, 2021 |
Feb. 04, 2021 |
|
| Debt Instrument [Line Items] | ||||||||||||||
| Revolving credit line facility amount | $ 3,750,000 | |||||||||||||
| Amount increased revenue percentage | 80.00% | |||||||||||||
| Maximum advance line | $ 17,500,000 | |||||||||||||
| Revolving credit line facility maximum amount | $ 3,750,000 | |||||||||||||
| Delivery percentage | 100.00% | |||||||||||||
| Revolving credit line facility interest free term | 45 days | |||||||||||||
| Revolving credit line facility deliveries of concentrates or cash free term | 120 days | |||||||||||||
| Description of line of credit | Beginning in September 2023, up to $10M of the ACL advance may be converted into a one-year installment loan (the “RCL”) bearing interest at 3M SOFR + 7.5% and amortized as follows: Month 1, interest only; Month 2-11, 5% principal plus interest; and Month 12, final 50% principal plus interest. | |||||||||||||
| Advance from buyer | $ 10,750,000 | $ 10,000,000 | $ 9,850,000 | $ 9,200,000 | $ 9,600,000 | $ 9,350,000 | ||||||||
| Conversion of advance to note payable | $ 9,750,000 | |||||||||||||
| Advances settlement date from buyers | Sep. 16, 2023 | Aug. 14, 2023 | Jun. 28, 2023 | May 17, 2023 | Mar. 31, 2023 | Feb. 16, 2023 | ||||||||
| Advance credit line facility, converted to installment note | Converted to a one-year note payable on December 1, 2023. | |||||||||||||
| Notes payable outstanding amount | $ 9,750,000 | |||||||||||||
| Additional amount received | $ 12,000,000 | |||||||||||||
| Interest expense notes payable | $ 1,249,098 | $ 108,098 | ||||||||||||
| Amended Note Agreement | ||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||
| Revolving credit line facility maximum amount | $ 12,500,000 | $ 12,500,000 | ||||||||||||
| Due date | Nov. 30, 2024 | |||||||||||||
| Conversion price per share | $ 1.61 | |||||||||||||
| Options Exercised | $ 4,000,000 | |||||||||||||
| Amended Note Agreement | Maximum | ||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||
| Additional amount received | $ 4,000,000 | |||||||||||||
| RCL into common stock | 9,000,000 | |||||||||||||
| X | ||||||||||
- Definition Advance credit line facility, converted to installment note. No definition available.
|
| X | ||||||||||
- Definition Advance from buyer. No definition available.
|
| X | ||||||||||
- Definition Advances Settlement Date From Buyers No definition available.
|
| X | ||||||||||
- Definition Amount increased revenue percentage. No definition available.
|
| X | ||||||||||
- Definition Conversion of advance to note payable. No definition available.
|
| X | ||||||||||
- Definition Credit Line Description No definition available.
|
| X | ||||||||||
- Definition Delivery percentage rate. No definition available.
|
| X | ||||||||||
- Definition Interest expense notes payable. No definition available.
|
| X | ||||||||||
- Definition Line of credit options exercised. No definition available.
|
| X | ||||||||||
- Definition Notes Payable Outstanding Amount No definition available.
|
| X | ||||||||||
- Definition Revolving credit line facility deliveries of concentrates or cash free term period. No definition available.
|
| X | ||||||||||
- Definition Revolving credit line facility interest free term period. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The fair value of line of credit assumed in noncash investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from a borrowing supported by a written promise to pay an obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|